Verano (VRNOF) Stock Price, News & Analysis

Company Overview

Verano Holdings Inc. (OTCMKTS: VRNOF) is a vertically integrated cannabis company engaged in cultivation, processing and retail operations across the United States. The company focuses on both medical and adult‐use markets, operating high‐quality cultivation facilities and dispensaries under several retail brands. Through its cultivation network, Verano produces flower, pre‐rolls, concentrates, vape cartridges, edibles and topicals, aiming to serve a wide range of consumer preferences and therapeutic applications.

Verano’s retail footprint extends across multiple states and territories, including Florida, Illinois, Massachusetts, Michigan, New Jersey, New York, Pennsylvania, Ohio, Maryland, Iowa, Missouri, Nevada and Puerto Rico. The company’s dispensaries operate under brand names such as Zen Leaf, MÜV, Rise and Essence, each tailored to local markets with design, product offerings and consumer experiences that reflect regional regulatory requirements and cultural preferences.

The company’s product portfolio encompasses a variety of branded offerings, including in‐house cultivars and partnerships with third‐party brands. Verano emphasizes quality control and compliance, with in‐house laboratories testing for potency and contaminants at each stage of production. In addition to standard flower and concentrates, the company has launched proprietary brands and exclusive product lines to differentiate its retail locations and wholesale channels.

Founded in 2018 through the merger of several regional operators, Verano is headquartered in Chicago, Illinois. The company is led by CEO George Archos, who has guided its expansion from a few local outlets to a multi‐state operator. Verano’s management team comprises executives with backgrounds in consumer packaged goods, pharmaceutical manufacturing and retail operations, reflecting the company’s dual emphasis on product quality and customer experience.

Key Stats

• Today's Range: $1.26 to $1.26
• 50-Day Range: $1.26 to $1.26
• 52-Week Range: $0.41 to $3.58
• Volume: N/A
• Average Volume: 476,705 shs
• Market Capitalization: $455.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

Verano Stock Analysis - MarketRank™

Verano scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Verano has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Verano has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Verano are expected to grow in the coming year, from ($0.18) to ($0.13) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Verano is -1.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Verano is -1.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Verano has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for VRNOF.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Verano does not currently pay a dividend.

Dividend Growth

Verano does not have a long track record of dividend growth.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: N/A

News Sentiment

Verano has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Verano insiders have not sold or bought any company stock.

Percentage Held by Insiders

9.10% of the stock of Verano is held by insiders.

Percentage Held by Institutions

8.98% of the stock of Verano is held by institutions.

Company Calendar

• Last Earnings: 10/29/2025
• Today: 6/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:VRNOF
• Previous Symbol: OTC:VRNOF
• CIK: 1848416
• Web: www.verano.com
• Phone: 312-265-0730
• Fax: N/A
• Employees: 3,800
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.98)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$341.86 million
• Net Margins: -41.68%
• Pretax Margin: -37.43%
• Return on Equity: -9.54%
• Return on Assets: -4.51%

Debt

• Debt-to-Equity Ratio: 0.56
• Current Ratio: 2.69
• Quick Ratio: 1.16

Sales & Book Value

• Annual Sales: $878.59 million
• Price / Sales: 0.52
• Cash Flow: $0.19 per share
• Price / Cash Flow: 6.66
• Book Value: $2.44 per share
• Price / Book: 0.52

Miscellaneous

• Outstanding Shares: 361,816,000
• Free Float: 328,891,000
• Market Cap: $455.89 million
• Optionable: Not Optionable
• Beta: 0.87